These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35083662)
1. IKKβ Alleviates Neuron Injury in Alzheimer's Disease via Regulating Autophagy and RIPK1-Mediated Necroptosis. Wang W; Gu X; Cheng Z; Lu X; Xie S; Liu X Mol Neurobiol; 2022 Apr; 59(4):2407-2423. PubMed ID: 35083662 [TBL] [Abstract][Full Text] [Related]
2. Roles of receptor-interacting protein kinase 1 in SH-SY5Y cells with beta amyloid-induced neurotoxicity. Chan HH; Leong CO; Lim CL; Koh RY J Cell Mol Med; 2022 Mar; 26(5):1434-1444. PubMed ID: 35106914 [TBL] [Abstract][Full Text] [Related]
3. TNF-α-dependent neuronal necroptosis regulated in Alzheimer's disease by coordination of RIPK1-p62 complex with autophagic UVRAG. Xu C; Wu J; Wu Y; Ren Z; Yao Y; Chen G; Fang EF; Noh JH; Liu YU; Wei L; Chen X; Sima J Theranostics; 2021; 11(19):9452-9469. PubMed ID: 34646380 [No Abstract] [Full Text] [Related]
4. Chlorogenic Acid Alleviates Aβ Gao L; Li X; Meng S; Ma T; Wan L; Xu S Drug Des Devel Ther; 2020; 14():1705-1716. PubMed ID: 32440096 [TBL] [Abstract][Full Text] [Related]
5. Lysosomal damage after spinal cord injury causes accumulation of RIPK1 and RIPK3 proteins and potentiation of necroptosis. Liu S; Li Y; Choi HMC; Sarkar C; Koh EY; Wu J; Lipinski MM Cell Death Dis; 2018 May; 9(5):476. PubMed ID: 29686269 [TBL] [Abstract][Full Text] [Related]
6. Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease. Chan HH; Koh RY; Lim CL; Leong CO Curr Alzheimer Res; 2019; 16(10):907-918. PubMed ID: 31642777 [TBL] [Abstract][Full Text] [Related]
7. Novel insights into RIPK1 as a promising target for future Alzheimer's disease treatment. Li S; Qu L; Wang X; Kong L Pharmacol Ther; 2022 Mar; 231():107979. PubMed ID: 34480965 [TBL] [Abstract][Full Text] [Related]
8. Inhibitor Kappa B Kinase β, Modulated by DJ-1/p-VHL, Reduces Phosphorylated Tau (p-Tau) Accumulation via Autophagy in Alzheimer's Disease Model. Chen WP; Zhang G; Cheng ZJ; Gu XH; Li M; Liu X Neuroscience; 2021 Jan; 452():1-12. PubMed ID: 33069779 [TBL] [Abstract][Full Text] [Related]
9. S14G-humanin alleviates insulin resistance and increases autophagy in neurons of APP/PS1 transgenic mouse. Han K; Jia N; Zhong Y; Shang X J Cell Biochem; 2018 Apr; 119(4):3111-3117. PubMed ID: 29058763 [TBL] [Abstract][Full Text] [Related]
10. DHA attenuates Aβ-induced necroptosis through the RIPK1/RIPK3 signaling pathway in THP-1 monocytes. Yuan S; Li H; Yang C; Xie W; Wang Y; Zhang J; Cai Z; Mao Z; Xie W; Lü T Biomed Pharmacother; 2020 Jun; 126():110102. PubMed ID: 32199223 [TBL] [Abstract][Full Text] [Related]
11. Park J; Ha HJ; Chung ES; Baek SH; Cho Y; Kim HK; Han J; Sul JH; Lee J; Kim E; Kim J; Yang YR; Park M; Kim SH; Arumugam TV; Jang H; Seo SW; Suh PG; Jo DG Sci Adv; 2021 Jan; 7(3):. PubMed ID: 33523877 [No Abstract] [Full Text] [Related]
12. Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy. Guo X; Lv J; Lu J; Fan L; Huang X; Hu L; Wang J; Shen X Neuropharmacology; 2018 Mar; 130():77-91. PubMed ID: 29197516 [TBL] [Abstract][Full Text] [Related]
13. Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing Aβ Zeng L; Zhang D; Liu Q; Zhang J; Mu K; Gao X; Zhang K; Li H; Wang Q; Zheng Y; Mao S Neuroscience; 2021 Mar; 458():141-152. PubMed ID: 33412244 [TBL] [Abstract][Full Text] [Related]
14. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease. Wang D; Fei Z; Luo S; Wang H Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672 [TBL] [Abstract][Full Text] [Related]
15. Injection of exogenous amyloid-β oligomers aggravated cognitive deficits, and activated necroptosis, in APP23 transgenic mice. Yu H; Morihara R; Ota-Elliott R; Bian Z; Bian Y; Hu X; Sun H; Fukui Y; Abe K; Ishiura H; Yamashita T Brain Res; 2023 Dec; 1821():148565. PubMed ID: 37683777 [TBL] [Abstract][Full Text] [Related]
16. Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease. Zhao W; Liu Y; Xu L; He Y; Cai Z; Yu J; Zhang W; Xing C; Zhuang C; Qu Z ACS Chem Neurosci; 2022 Jun; 13(12):1697-1713. PubMed ID: 35607807 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-155-5p Targets SKP2, Activates IKKβ, Increases Aβ Aggregation, and Aggravates a Mouse Alzheimer Disease Model. Wang W; Gu XH; Li M; Cheng ZJ; Tian S; Liao Y; Liu X J Neuropathol Exp Neurol; 2022 Jan; 81(1):16-26. PubMed ID: 34865098 [TBL] [Abstract][Full Text] [Related]
18. RIPK1 mediates a disease-associated microglial response in Alzheimer's disease. Ofengeim D; Mazzitelli S; Ito Y; DeWitt JP; Mifflin L; Zou C; Das S; Adiconis X; Chen H; Zhu H; Kelliher MA; Levin JZ; Yuan J Proc Natl Acad Sci U S A; 2017 Oct; 114(41):E8788-E8797. PubMed ID: 28904096 [TBL] [Abstract][Full Text] [Related]
19. Necroptosis and Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Opportunities. Zhang R; Song Y; Su X J Alzheimers Dis; 2023; 94(s1):S367-S386. PubMed ID: 36463451 [TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model. Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]